How to Get Pigment Back in Skin: Treatments That Work

Pigment can return to depigmented skin, but the treatment that works depends on why the pigment disappeared in the first place. Vitiligo, hypopigmented scars, and age-related white spots each involve different mechanisms and respond to different therapies. The good news is that options have expanded considerably in recent years, including the first FDA-approved topical medication specifically for vitiligo repigmentation. Getting results usually means starting treatment early, being patient through months of gradual change, and sometimes combining more than one approach.

Why Pigment Disappears

Skin color comes from melanocytes, the cells that produce the pigment melanin. When those cells are damaged, destroyed, or go dormant, the skin loses color. In vitiligo, the most studied cause of pigment loss, the immune system attacks melanocytes directly. Research has confirmed that a specific type of immune cell, CD8+ T cells, infiltrates the skin at the edges of vitiligo patches and triggers melanocyte death.¹ This autoimmune process makes vitiligo fundamentally different from other causes of light patches, like post-inflammatory hypopigmentation after a burn or the small white spots that appear with aging.

The distinction matters because treatments that calm the immune attack on melanocytes work well for vitiligo but do little for a scar that simply lacks pigment-producing cells. Before jumping into any treatment, getting the right diagnosis is the essential first step.

Where New Pigment Comes From

One of the more surprising facts about repigmentation is where the new color actually originates. The hair follicle acts as a reservoir for melanocyte precursor cells. These stem cells sit in the bulge region of the hair follicle, and when treatments stimulate repigmentation, those precursor cells wake up, multiply, migrate outward, and mature into functioning melanocytes that repopulate the surrounding skin.² This is why repigmentation often appears first as small dots of color around hair follicles, gradually expanding outward until the dots merge.

This follicular reservoir also explains a frustrating clinical pattern: areas of the body with dense hair, like the scalp and face, tend to repigment more easily than areas with sparse or fine hair, such as the fingertips, wrists, and lips. The melanocyte stem cells in hair follicles serve as the primary supply line for new pigment cells.³ Skin that has turned white and also lost its hair color in the affected area may have a depleted reservoir, making repigmentation harder to achieve. Signaling pathways including beta-catenin help drive these precursor cells to proliferate and differentiate, and some current treatments work in part by activating these pathways.⁴

Topical Treatments for Vitiligo

Topical therapies are the starting point for most people with vitiligo, especially for patches on the face and neck where results tend to be best. Two main classes dominate.

Calcineurin Inhibitors

Tacrolimus ointment has been used off-label for vitiligo for years and has a solid evidence base. A multicenter randomized trial found that 65% of patients using tacrolimus 0.1% on facial vitiligo achieved treatment success by 24 weeks, compared with 0% of those using a vehicle cream.⁵ A comprehensive review of the literature found that meaningful repigmentation typically doesn’t appear before two months of use, with peak results coming after about six months of twice-daily application. Facial lesions respond best, and the proportion of patients who see no response at all is relatively small, generally under 15%.⁶ Side effects are mostly limited to local burning or itching, with no systemic issues reported.

Topical corticosteroids are another option, particularly for limited areas of the body. They are generally used in short courses to avoid skin thinning, which makes them less practical for the months-long treatment periods that repigmentation requires. For the face, many dermatologists prefer tacrolimus over steroids precisely because of that thinning risk.

Ruxolitinib Cream

Ruxolitinib cream became the first treatment specifically approved for vitiligo repigmentation. It works by blocking JAK1 and JAK2, enzymes involved in the immune signaling that drives melanocyte destruction. Two large phase 3 trials showed that about 30% of patients achieved at least 75% improvement in facial vitiligo severity at 24 weeks, compared with roughly 7–11% with a placebo cream.⁷ Those numbers climb with continued use. A pooled analysis of the same trials found that by week 52, about half of patients who kept applying the cream reached 75% facial repigmentation.⁸

One of the more encouraging findings is that the results held across different patient groups regardless of age, skin tone, or baseline severity. The cream was well tolerated through 52 weeks of use, with the earlier phase 2 trial also reporting good tolerability.⁹ The main limitation is cost and insurance coverage, which can be significant barriers for a medication that needs to be used for many months.

Phototherapy and Light Treatment

Narrowband UVB phototherapy has been a mainstay of vitiligo treatment for decades and remains one of the most effective options, especially for widespread disease. It works by stimulating the melanocyte precursor cells in hair follicles to proliferate and migrate into the depigmented skin. Research has shown that NB-UVB activates specific signaling pathways in these bulge stem cells that drive repigmentation.¹⁰

Treatment typically involves two to three sessions per week in a dermatologist’s office or with a prescribed home unit. Most patients need several months before seeing clear results, and a year or more of treatment isn’t unusual for extensive disease. The face, neck, and trunk tend to respond better than the hands and feet, echoing that follicular reservoir pattern. NB-UVB is often combined with topical treatments to boost results. Adding a topical like tacrolimus or ruxolitinib cream to phototherapy can improve repigmentation rates beyond what either treatment achieves alone, though the evidence base for specific combination protocols is still being built out.

When Topicals and Light Aren’t Enough

For vitiligo that is rapidly spreading, some dermatologists use low-dose oral corticosteroids in a mini-pulse regimen to stabilize the disease. This approach has shown some ability to halt progression and produce partial repigmentation, particularly in early or fast-moving vitiligo. The goal is stabilization first, with repigmentation therapies added once the disease stops advancing.

Surgical Options for Stable Vitiligo

When vitiligo has been stable for at least a year and topical and light treatments haven’t produced adequate results, surgical approaches can transplant functioning melanocytes into the white patches. Several techniques are available.

Punch grafting is the simplest, involving small plugs of normally pigmented skin placed into the depigmented area. Split-thickness skin grafting takes a thin layer of pigmented skin from a donor site and applies it to the vitiligo patch; this approach has been used on a range of lesion types with patients typically needing two to three sessions.¹¹ Cellular grafting takes this a step further by separating out individual melanocytes and keratinocytes from a small donor sample, then applying these cells as a suspension to the depigmented area. This method can treat a larger area from a smaller donor site and has become the preferred surgical approach in many centers.¹²

Surgical techniques have grown considerably in popularity and sophistication over recent decades.¹³ The main requirements are stable disease and realistic expectations about cosmetic matching between the grafted and surrounding skin. Surgery works best for segmental vitiligo, the type that affects one side of the body and tends to stabilize on its own, and for focal patches that haven’t responded to other treatments.

Repigmenting Scars

Hypopigmented scars, particularly from burns, are a different challenge from vitiligo. The melanocytes may have been physically destroyed or displaced by the injury, and the skin’s architecture is altered by scar tissue. Fractional lasers have shown real promise here. These devices create microscopic channels in the scar tissue, which seems to stimulate melanocyte migration and new pigment production.

A randomized trial using fractional CO2 laser on hypopigmented burn scars found that about 64% of patients experienced some measurable improvement in pigmentation, though the degree of repigmentation was modest for most.¹⁴ Better results have been reported with non-ablative fractional lasers combined with topical prostaglandin analogs like bimatoprost. In one study, five of seventeen patients achieved over 75% improvement in scar hypopigmentation, and twelve achieved over 50% improvement, with results lasting through a follow-up period averaging about 20 months.¹⁵ The laser creates micro-channels that enhance absorption of the topical agent, while the prostaglandin analog promotes melanin production. A case report using a non-ablative 1927 nm thulium laser with bimatoprost showed near-complete pigment return after 18 weeks of treatment.¹⁶

These laser-based approaches are still relatively new, and protocols aren’t fully standardized. But for people with prominent white scars from burns or surgery, they represent one of the few evidence-backed options.

Those Small White Spots That Come With Age

Idiopathic guttate hypomelanosis, often just called IGH, produces small porcelain-white spots, usually a few millimeters across, on sun-exposed skin like the forearms and shins. It’s extremely common in people over 40 and becomes more likely with age.¹⁷ Unlike vitiligo, IGH isn’t autoimmune. It appears to result from a combination of cumulative sun damage and natural aging of melanocytes.

The frustrating reality is that there’s no standard treatment that reliably works for IGH. Dermatologists have tried a wide range of approaches, including topical retinoids, calcineurin inhibitors, cryotherapy, superficial dermabrasion, chemical peels, and various laser treatments, all with mixed results.¹⁸ Fractional lasers and cryotherapy seem to be among the more promising options based on case series, but nothing has been validated in large controlled trials. For many people, the spots are purely cosmetic and the most practical approach is sun protection to prevent new ones and cosmetic camouflage for existing ones.

Treatments for Children

Vitiligo often appears in childhood, and parents understandably want to act quickly. The treatment landscape for kids overlaps with adults but with some important differences. A systematic review and meta-analysis of tacrolimus ointment in pediatric vitiligo found that about 29% of children achieved excellent repigmentation and another 26% achieved moderate improvement. Only about 8% showed no response at all. No systemic side effects were reported, with local reactions limited mainly to a burning sensation in about 11% and itching in about 9%.¹⁹

Early intervention appears to matter. Emerging evidence suggests that topical calcineurin inhibitors, corticosteroids, and phototherapy can produce moderate repigmentation in pediatric segmental vitiligo when started promptly. Topical JAK inhibitors like ruxolitinib have shown promising results in limited pediatric cases, though the evidence base is still small. Surgical approaches, while potentially more effective, carry a higher risk of complications in younger patients and are generally reserved for stable, localized disease that hasn’t responded to other treatments.²⁰

The Role of Nutrition and the Gut

You’ll find plenty of claims online about vitamins, supplements, and diet curing pigment loss. The evidence is thin but not entirely absent. One small randomized trial found that ginkgo biloba extract significantly slowed the progression of limited, slowly spreading vitiligo and produced marked to complete repigmentation in ten patients on the supplement compared with two in the placebo group.²¹ That’s intriguing, but it’s one small study and shouldn’t be taken as definitive.

Research into the gut microbiome and vitiligo is at an early stage. Studies in Indian populations have found differences in gut bacteria between people with vitiligo and healthy controls, with patterns that resemble those seen in other autoimmune conditions.²² Whether modifying the gut microbiome through diet or probiotics could actually influence the disease remains speculative. The specific impact of diet on the gut microbiome of vitiligo patients hasn’t been directly studied yet.²³ Antioxidant-rich diets probably don’t hurt, but no dietary approach should replace proven medical treatments.

The Emotional Weight of Pigment Loss

Pigment loss isn’t just cosmetic. A global study of over 3,500 people with vitiligo found substantial psychosocial burden, with about half of patients reporting that vitiligo made them feel less confident or more self-conscious. The burden was especially pronounced among people with darker skin tones, those with patches on the face or hands, and those with more extensive disease. More than a third of patients reported that vitiligo affected their self-esteem, relationships, and careers.²⁴ This emotional impact is one reason why pursuing treatment is legitimate even when vitiligo doesn’t cause physical symptoms. It also means that psychological support, whether through counseling, support groups, or simply an empathetic dermatologist, is a meaningful part of care.

Chemical Exposure as a Cause

Not all depigmentation comes from autoimmunity or aging. Certain chemical exposures can directly damage melanocytes and cause white patches that look like vitiligo but have a distinct cause. Rhododendrol, a skin-lightening ingredient that was used in some cosmetic products in Japan, caused an outbreak of chemical leukoderma. Research into that incident showed that the chemical damaged adhesion molecules in both melanocytes and the surrounding skin cells, causing melanocytes to detach from the skin’s basal layer.²⁵ Other chemicals known to trigger depigmentation include certain phenols found in industrial settings, rubber compounds, and some hair dyes. If you developed white patches after starting a new product or working with new chemicals, mention it to your dermatologist. Chemical-induced leukoderma can sometimes improve after the offending exposure is identified and removed, though it may also need the same treatments used for vitiligo.

What Future Treatments Might Look Like

Even when vitiligo responds to treatment and patches repigment, the disease often recurs once therapy is stopped. This happens in part because immune memory cells, specifically a population of CD8+ T cells that take up permanent residence in the skin, persist even after visible repigmentation. These resident memory T cells are thought to maintain the disease by lying dormant and then reactivating.²⁶ Researchers have proposed that selectively depleting or neutralizing these skin-resident memory T cells could produce a more durable remission than current treatments, which suppress the immune response but don’t eliminate the cells responsible for it.²⁷

This line of research is still preclinical and early-phase, but it represents a genuine shift in how the field thinks about vitiligo treatment. Current therapies are largely about managing the immune attack while it’s happening. A treatment that could clear the memory cells responsible for relapse would be a fundamentally different kind of therapy, one aimed at cure rather than control. Whether that arrives as a biologic injection, a next-generation topical, or something else entirely remains to be seen, but the target is increasingly clear.

Practical Timelines and Expectations

Regardless of the treatment you and your dermatologist choose, patience is nonnegotiable. Most repigmentation therapies take three to six months before visible improvement appears, and optimal results often require a full year or longer of consistent treatment. Facial skin tends to respond fastest, extremities slowest. Color match between repigmented and surrounding skin can be imperfect, especially with surgical methods, though it usually improves with time and sun exposure.

Maintenance therapy matters too. Because vitiligo is a chronic autoimmune condition, many dermatologists recommend some form of ongoing treatment, whether that’s a lower frequency of phototherapy sessions or continued use of a topical cream a few days per week, to prevent relapse. For non-vitiligo causes like scars or IGH, the timeline and maintenance needs are different, but the core lesson is the same: pigment restoration is a slow process, and the best results come from sustained commitment to a treatment plan.